Phylloides tumours are uncommon biphasic lesions of breast that are further classified as benign, borderline & malignant. Malignant phylloides tumours must be distinguished from spindle cell carcinoma and primary breast sarcoma. Demonstration of benign epithelial component will help to establish the diagnosis of malignant phylloides, but this may require extensive sampling is some cases. The present case was diagnosed after extensive sampling.
INTRODUCTION
Phylloides tumours are uncommon biphasic lesion that account for 1% or less of all primary breast tumours. Most patients are middle aged or elderly. Phylloides are classified as malignant depending on several histologic criteria's. [1] [2] [3] [4] However the most reliable criteria for predicting malignant behaviour in a phylloides is the presence of heterologous sarcomatous element i.e. liposarcoma, Rhabdomyosaroma and osteosarcoma. Demonstration of benign epithelial component will help to establish the diagnosis of phylloided tumour but this may require extensive sampling in some cases. It should be noted that a sarcomatous lesion in the breast is more likely to represent a malignant phylloides than a primary sarcoma or a metastatic sarcoma from another site. [5] In one large study the risk of local recurrence (36%) among patients treated with wide local excision and frequency of metastasis was 20-25%. Most tumours that metastasize have obviously sarcomatous features and stromal overgrowth. The presence of heterologous elements appear to be indicative of a particularly poor prognosis. [6] [7] [8] [9] [10] [11] The most common metastatic sites are lungs & bones. Axillary node metastasis is rare. In our case no metastasis was seen at present.
CONCLUSION
This is a rare case of Malignant Phylloides tumour with giant cells and rhabdomyosarcomatous differentiation. Extensive sampling was required to demonstrate the benign epithelial component. Primary sarcomatous tumours of breast are very rare so any sarcomatous growth in the breast should be extensively sampled to demonstrate any benign epithelial component thus rightly diagnosing the lesion.
